Abbott Laboratories (FRA:ABL)

Market Cap	192.24B
Revenue (ttm)	36.71B
Net Income (ttm)	11.86B
Shares Out	n/a
EPS (ttm)	6.79
PE Ratio	16.21
Forward PE	23.77
Dividend	2.10 (1.91%)
Ex-Dividend Date	Jul 15, 2025

Volume	520
Average Volume	216
Open	111.82
Previous Close	113.46
Day's Range	109.82 - 111.82
52-Week Range	97.94 - 133.78
Beta	n/a
RSI	44.80
Earnings Date	Jul 16, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ABL

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD